NMTC — NEUROONE MEDICAL TECHNOLOGIES Corp
—
Nasdaq ·
Health Care ·
Health Care Equipment & Supplies ·
CIK 1500198 ·
Last close
$1.12
Market Cap
$10.20M
52W High
$6.42
52W Low
$0.96
ADV30
185,372
Next earnings
2026-08-13
Quarterly Fundamentals
Revenues vs Net Income (last 4 Q)
Assets vs Liabilities (last 4 Q)
| Period | Revenues | Gross profit | Op income | Net income | Assets | Cash | Liabilities |
|---|---|---|---|---|---|---|---|
| Jun 2026 | 1,973,105 | 1,182,609 | -2,424,312 | -2,006,331 | 6,186,095 | 2,047,596 | 2,418,552 |
| Mar 2026 | 2,391,185 | 1,286,617 | -2,100,844 | -2,085,669 | 7,864,958 | 2,804,011 | 2,491,322 |
| Dec 2025 | 2,892,635 | 1,567,828 | -1,707,307 | -1,437,890 | 8,577,602 | 3,561,616 | 2,175,677 |
| Sep 2025 | 2,740,925 | 1,528,621 | -1,371,064 | -1,619,221 | 10,785,647 | 6,570,382 | 3,713,125 |
Cashflow TTM (yfinance, fills SEC gap)
Operating CF
$-7,433,723
Investing CF
$-133,425
Financing CF
$9,050,908
CapEx
$-133,425
Dividends Paid
—
Buybacks
$-70,654
EPS Diluted TTM
$-1.06
As of
2026-08-16
Balance + Analyst (yfinance extras)
Retained Earnings
$-82,133,346
Inventory
$1,866,633
Receivables
$2,426,518
ST Investments
—
EBIT TTM
$-6,930,676
Pretax Income TTM
$-6,940,001
Interest Exp TTM
$9,325
Analysts
3
Yahoo Snapshot (yfinance, live)
Total Revenue
$12,468,715
EBITDA
$-7,663,002
Free Cash Flow
$-4,566,159
Enterprise Value
$12,332,739
Total Cash
$2,047,596
Total Debt
$175,345
Shares Out
9,105,763
Trailing EPS
$-0.97
Book Value
$0.43
ROE
-124.7%
ROA
-58.1%
Div Yield
—
Annual Trend (SEC EDGAR, last 4y)
Revenues vs Net Income (last 4y)
| FY end | Revenues | Op income | Net income | Assets | Liabilities | Equity | Op cash flow |
|---|---|---|---|---|---|---|---|
| Sep 2025 | 9,097,692 | -4,226,473 | -3,605,374 | 10,785,647 | 3,713,125 | 7,072,522 | -2,837,272 |
| Sep 2024 | 3,453,003 | -11,887,209 | -12,318,110 | 5,369,940 | 4,547,927 | 822,013 | -11,011,840 |
| Sep 2023 | 1,952,441 | -11,955,250 | -11,859,491 | 8,097,314 | 1,847,910 | 6,249,404 | -12,886,874 |
| Sep 2022 | 171,169 | -10,030,765 | -9,999,613 | 12,822,609 | 3,218,245 | 9,604,364 | -7,519,534 |
TTM Snapshot
Revenues TTM
$9,720,795
NetIncome TTM
$-6,643,648
OpCashFlow TTM
—
Assets (Latest)
$7,864,958
Forward EPS
$-0.28
Peers — same industry
| Ticker | Name | Market Cap | Last | Daily % |
|---|---|---|---|---|
| UEEC | United Health Products, Inc. | $10.53M | $0.04 | — |
| RGNT | REGENTIS BIOMATERIALS LTD. | $11.24M | $1.60 | — |
| ALRTF | ALR Technologies SG Ltd. | $11.77M | $0.02 | — |
| CTSO | Cytosorbents Corp | $11.94M | $3.79 | — |
| PLSM | Pulsenmore Ltd. | $12.03M | $1.85 | — |
News headlines (Yahoo Finance, 1h cache)
NeuroOne® Joins Dartmouth-Led Research Team on $1 Million NIH Grant to Advance Neurotransmitter Sensing Technology
2026-10-08 20:01 · Yahoo
NeuroOne Reports Preliminary Fiscal Q4 Product Revenue Growth of 38.4%; Secures Record $4.5 Million Purchase Order
2026-10-05 13:17 · Yahoo
NeuroOne Announces Successful Robotic-Assisted Drug Delivery Using Next-Generation StereoCED(TM) Platform
2026-08-27 13:05 · Yahoo
NeuroOne (NMTC) Q3 2026 Earnings Call Transcript
2026-08-20 15:13 · Yahoo
NeuroOne Medical Technologies Corp (NMTC) (Q3 2026) Earnings Call Highlights: Revenue Grows 16% ...
2026-08-17 19:03 · Yahoo
NeuroOne(R) to Report Third Quarter Fiscal Year 2026 Financial Results on Thursday, August 13, 2026, at 8:30 a.m. Eastern Time
2026-08-03 12:30 · Yahoo
NeuroOne(R) Highlights Potential Paradigm Shift for Patients Treated With the OneRF(R) Brain Ablation System Based on Reports by Physicians
2026-07-28 12:30 · Yahoo
NeuroOne(R) Expands Drug Delivery Program Through Collaboration on Pediatric Brain Cancer Clinical Trial
2026-07-16 12:30 · Yahoo
NeuroOne(R) Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
2026-06-25 21:00 · Yahoo
NeuroOne(R) Announces Preliminary Inclusion in Russell Microcap(R) Index
2026-06-16 12:30 · Yahoo
Recent Insider Activity
No insider activity indexed for this ticker.